Literature DB >> 11005865

Antibodies have the intrinsic capacity to destroy antigens.

A D Wentworth1, L H Jones, P Wentworth, K D Janda, R A Lerner.   

Abstract

Research throughout the last century has led to a consensus as to the strategy of the humoral component of the immune system. The essence is that, for killing, the antibody molecule activates additional systems that respond to antibody-antigen union. We now report that the immune system seems to have a previously unrecognized chemical potential intrinsic to the antibody molecule itself. All antibodies studied, regardless of source or antigenic specificity, can convert molecular oxygen into hydrogen peroxide, thereby potentially aligning recognition and killing within the same molecule. Aside from pointing to a new chemical arm for the immune system, these results may be important to the understanding of how antibodies evolved and what role they may play in human diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11005865      PMCID: PMC27126          DOI: 10.1073/pnas.97.20.10930

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Formation of singlet oxygen by the myeloperoxidase-mediated antimicrobial system.

Authors:  H Rosen; S J Klebanoff
Journal:  J Biol Chem       Date:  1977-07-25       Impact factor: 5.157

2.  Cytochemical demonstration of sites of hydrogen peroxide generation and increased vascular permeability in isolated pig hearts after ischaemia and reperfusion.

Authors:  J N Skepper; R N Pierson; V K Young; J A Rees; J M Powell; V Navaratnam; N R Cary; D N Tew; P J Bacon; J Wallwork; D J White; D K Menon
Journal:  Microsc Res Tech       Date:  1998-09-01       Impact factor: 2.769

Review 3.  Catalytic antibodies.

Authors:  P Wentworth; K D Janda
Journal:  Curr Opin Chem Biol       Date:  1998-02       Impact factor: 8.822

Review 4.  Antibody: the flexible adaptor molecule.

Authors:  D R Burton
Journal:  Trends Biochem Sci       Date:  1990-02       Impact factor: 13.807

5.  A functional model of the human C1 complex Emergence of a functional model.

Authors:  G J Arlaud; M G Colomb; J Gagnon
Journal:  Immunol Today       Date:  1987

6.  Mechanisms of photosensitized oxidation. There are several different types of photosensitized oxidation which may be important in biological systems.

Authors:  C S Foote
Journal:  Science       Date:  1968-11-29       Impact factor: 47.728

Review 7.  Aromatic-aromatic interaction: a mechanism of protein structure stabilization.

Authors:  S K Burley; G A Petsko
Journal:  Science       Date:  1985-07-05       Impact factor: 47.728

Review 8.  Photochemical inactivation of enzymes.

Authors:  L I Grossweiner
Journal:  Curr Top Radiat Res Q       Date:  1976-03

9.  A quantitative determination of singlet oxygen with horseradish peroxidase.

Authors:  M Kreitner; G Alth; H Koren; S Loew; R Ebermann
Journal:  Anal Biochem       Date:  1993-08-15       Impact factor: 3.365

10.  A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases.

Authors:  M Zhou; Z Diwu; N Panchuk-Voloshina; R P Haugland
Journal:  Anal Biochem       Date:  1997-11-15       Impact factor: 3.365

View more
  37 in total

1.  Ozone in biology.

Authors:  Richard A Lerner; Albert Eschenmoser
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-11       Impact factor: 11.205

2.  Evidence for the production of trioxygen species during antibody-catalyzed chemical modification of antigens.

Authors:  Paul Wentworth; Anita D Wentworth; Xueyong Zhu; Ian A Wilson; Kim D Janda; Albert Eschenmoser; Richard A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

Review 3.  B1b lymphocyte-derived antibodies control Borrelia hermsii independent of Fcα/μ receptor and in the absence of host cell contact.

Authors:  Matthew J Colombo; David Abraham; Akira Shibuya; Kishore R Alugupalli
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

4.  High levels of catalytic antibodies correlate with favorable outcome in sepsis.

Authors:  Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Srini V Kaveri; David Hayon-Sonsino; Nithyananda Thorenoor; Julien Charpentier; Charles-Edouard Luyt; Jean-Paul Mira; Valakunja Nagaraja; Michel D Kazatchkine; Jean-François Dhainaut; Vincent O Mallet
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

Review 5.  FLT3 antibody-based therapeutics for leukemia therapy.

Authors:  Yiwen Li; Zhenping Zhu
Journal:  Int J Hematol       Date:  2005-08       Impact factor: 2.490

6.  Chemical modifications in therapeutic protein aggregates generated under different stress conditions.

Authors:  Quanzhou Luo; Marisa K Joubert; Riki Stevenson; Randal R Ketchem; Linda O Narhi; Jette Wypych
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

7.  Adduction of cholesterol 5,6-secosterol aldehyde to membrane-bound myelin basic protein exposes an immunodominant epitope.

Authors:  Natalie K Cygan; Johanna C Scheinost; Terry D Butters; Paul Wentworth
Journal:  Biochemistry       Date:  2011-02-28       Impact factor: 3.162

8.  The self-organizing fractal theory as a universal discovery method: the phenomenon of life.

Authors:  Alexei Kurakin
Journal:  Theor Biol Med Model       Date:  2011-03-29       Impact factor: 2.432

Review 9.  Catalytic antibodies in healthy humans and patients with autoimmune and viral diseases.

Authors:  G A Nevinsky; Valentina N Buneva
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310

10.  The leucine zipper domains of the transcription factors GCN4 and c-Jun have ribonuclease activity.

Authors:  Yaroslav Nikolaev; Christine Deillon; Stefan R K Hoffmann; Laurent Bigler; Sebastian Friess; Renato Zenobi; Konstantin Pervushin; Peter Hunziker; Bernd Gutte
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.